证券代码：830974 证券简称：凯大催化 公告编号：2025-006 杭州凯大催化金属材料股份有限公司 第四届监事会第十次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 27 日 2.会议召开地点：全资子公司浙江凯大催化新材料有限公司会议室（浙江省湖州 市长兴县城南工业园区经五路 8 号） 会议应出席监事 3 人，出席和授权出席监事 3 人。 监事邬学军因工作原因以通讯方式参与表决。 3.会议召开方式：现场和通讯 4.发出监事会会议通知的时间和方式：2025 年 4 月 11 日以书面方式发出 5.会议主持人：监事会主席邬学军先生 6.召开情况合法、合规、合章程性说明： 会议的召集、召开和表决程序符合有关法律、法规及《公司章程》的有关规 定。 （二）会议出席情况 二、议案审议情况 （一）审议通过《关于 2024 年年度报告及摘要的议案》 1.议案内容： 公司监事会对公司 2024 年年度报告及摘要进行了审 ...

证券代码：830974 证券简称：凯大催化 公告编号：2025-005 （一）会议召开情况 1.会议召开时间：2025 年 4 月 27 日 杭州凯大催化金属材料股份有限公司 第四届董事会第十二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 2.会议召开地点：全资子公司浙江凯大催化新材料有限公司会议室（浙江省 湖州市长兴县城南工业园区经五路 8 号） 3.会议召开方式：现场和通讯 4.发出董事会会议通知的时间和方式：2025 年 4 月 11 日以书面方式发出 5.会议主持人：董事长姚洪先生 6.会议列席人员：全体监事、高级管理人员 7.召开情况合法、合规、合章程性说明： 会议的召集、召开和表决程序符合有关法律、法规及《公司章程》的有关规 定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 董事姚洪、谭志伟、郑刚、唐向红、朱建林、史莉佳和彭兵因工作原因以通 讯方式参与表决。 二、议案审议情况 （一）审议通过《关于 2024 年年度报告及 ...

Financial Performance - Operating revenue for Q1 2025 was CNY 209,602,506.82, down 26.28% from CNY 284,309,844.38 in Q1 2024[10] - Net profit attributable to shareholders for Q1 2025 was CNY 5,838,680.16, a decline of 41.24% compared to CNY 9,931,547.83 in the same period last year[10] - Total operating revenue for Q1 2025 was ¥209.60 million, a decrease of 26.3% compared to ¥284.31 million in Q1 2024[38] - Net profit for Q1 2025 was ¥5.84 million, a decline of 41.5% from ¥9.92 million in Q1 2024[39] - The company's total profit for Q1 2025 was approximately ¥2.06 million, down from ¥11.34 million in Q1 2024, reflecting a decrease of about 81.8%[42] Cash Flow - The net cash flow from operating activities increased by 155.41% to CNY 39,311,230.88, compared to a negative cash flow of CNY 70,949,432.04 in Q1 2024[10] - The net cash flow from operating activities was $8,393,425.38, a significant improvement compared to a net outflow of $78,804,482.05 in the previous period[47] - Total cash outflow from operating activities amounted to $262,237,142.15, down from $366,317,963.12 year-over-year[47] - The cash flow from financing activities for Q1 2025 was negative at approximately -¥42.00 million, compared to -¥42.26 million in Q1 2024, showing a slight improvement[45] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 757,312,611.39, a decrease of 3.46% compared to the end of 2024[10] - The company's total liabilities to assets ratio decreased to 15.27% from 18.95% year-over-year[10] - The total liabilities decreased from CNY 148,669,835.46 to CNY 115,668,371.51, a reduction of about 22.19%[32] - Current assets totaled CNY 475,001,642.08, down from CNY 501,359,228.85, indicating a decrease of about 5.25%[29] Shareholder Information - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 13.95% of the total shares[17] - Zheng Gang, another significant shareholder, holds 7,850,000 shares, accounting for 4.79% of the total shares[18] - The total number of shares held by the top ten shareholders is 59,801,282, which constitutes 36.51% of the total shares[18] Research and Development - Research and development expenses decreased by 51.06% to CNY 1,132,626.58, attributed to reduced material requisition during the reporting period[12] - Research and development expenses for Q1 2025 were approximately ¥1.04 million, a decrease from ¥1.99 million in Q1 2024, reflecting a reduction of about 47.9%[42] Legal and Compliance - The company received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws on March 21, 2025[26] - The company has no ongoing litigation or arbitration matters during the reporting period[22] - The company has fulfilled all disclosed commitments without any overdue or violations[25] Other Financial Metrics - The weighted average return on equity based on net profit attributable to shareholders was 0.91%, down from 1.31% in the previous year[10] - Basic earnings per share for Q1 2025 were ¥0.04, compared to ¥0.05 in Q1 2024[40] - The company reported a financial expense of -¥835,943.23 in Q1 2025, an improvement from -¥1,030,544.23 in Q1 2024[38]

Industrial Development and R&D - The company is completing the industrial plant project in Hangzhou, expected to be operational in the second half of 2025, focusing on the production of precious metal catalytic materials and enhancing operational capabilities [7]. - The new industrial project will include three centers: a production center for new energy materials, a high-end materials R&D center, and an operations center to integrate supply chain management [7]. - The company is expanding its R&D capabilities and aims to enhance its core competitiveness and innovation levels continuously [9][10]. - The company has developed new products, including platinum-based catalysts for hydrogen fuel cells, enhancing its product offerings in the market [46]. - The company is focusing on the development of new products and technologies to enhance product performance and reduce costs, particularly in the precious metal catalyst sector [112]. - The company is actively developing new catalytic materials aimed at meeting stricter emission standards, which is expected to enhance its market competitiveness [98]. - The company is focusing on the development of palladium/alumina catalysts for coal and natural gas chemical applications, aiming to expand its market presence in these sectors [52]. - The company is committed to the domestic production of precious metal catalysts, with a focus on increasing market share and developing local capabilities [111]. - The company is focusing on expanding its market presence through new product development and technological advancements in catalytic materials [98]. - The company is collaborating with South Central University for the production and research of catalysts, aiming to optimize production technology and develop new products [102]. Financial Performance - The company's total revenue for 2024 was ¥1,061,608,140.89, representing a decrease of 22.08% compared to ¥1,362,415,750.08 in 2023 [31]. - The net profit attributable to shareholders for 2024 was ¥20,325,941.04, an increase of 75.04% from ¥11,612,490.86 in 2023 [31]. - The gross profit margin improved to 3.32% in 2024 from 2.23% in 2023 [31]. - Total assets decreased by 17.98% to ¥784,478,777.76 in 2024 from ¥956,413,439.78 in 2023 [32]. - Total liabilities were reduced by 52.62% to ¥148,669,835.46 in 2024 from ¥313,764,391.39 in 2023 [32]. - The company's current ratio increased to 3.49 in 2024 from 2.25 in 2023, indicating improved liquidity [32]. - The weighted average return on equity (ROE) based on net profit was 3.25% in 2024, up from 1.90% in 2023 [31]. - The basic earnings per share for 2024 was ¥0.12, a 71.43% increase from ¥0.07 in 2023 [31]. - The company reported a net cash flow from operating activities of ¥23,628,705.03, a decrease of 28.61% from ¥33,099,444.70 in 2023 [32]. - The company reported non-recurring gains totaling 7,428,269.42 in 2024, up 68.1% from 4,418,036.01 in 2023 [38]. Market Position and Strategy - The company has maintained its business model focused on the research, development, manufacturing, and recycling of precious metal catalytic materials, primarily serving the automotive, petrochemical, and pharmaceutical industries [46]. - The company aims to reduce reliance on foreign materials by targeting the domestic market for key materials, achieving performance levels that meet international standards [47]. - The company is focusing on talent acquisition to improve management and technical capabilities, ensuring alignment with future development needs [115]. - The company is actively optimizing its customer structure and strengthening long-term partnerships with core clients, leading to an increase in product sales and processing volume [51]. - The company is committed to leveraging capital markets to enhance its overall strength and capture industry opportunities for sustainable development [54]. Regulatory and Compliance Issues - The company received a warning letter from the China Securities Regulatory Commission for inaccurate disclosure of performance forecasts and financial data [146]. - The company was subject to disciplinary action from the Beijing Stock Exchange for disclosure violations, resulting in a public reprimand [147]. - The company’s management team, including the chairman and general manager, received individual warnings related to the disclosure issues [148]. - The company has confirmed the existence of external guarantees and significant related party transactions during the reporting period [124]. Environmental and Sustainability Initiatives - The company aims to significantly reduce pollutant emission intensity by 10% by 2025 as part of its industrial green development plan [200]. - By 2025, the company targets an 18% reduction in carbon dioxide emissions per unit of GDP compared to 2020 levels [200]. - The company plans to improve air quality, with a goal of achieving a 10% reduction in PM2.5 concentration and an 87.5% ratio of good air quality days by 2025 [200]. - The company emphasizes the importance of environmental protection in its production processes, adhering to national standards and conducting strict environmental assessments for projects [108]. Shareholder and Governance Information - The total number of ordinary shares is 163,800,000, with 78.62% being unrestricted shares at the end of the period [152]. - The company’s major shareholders include Yao Hong with 22,855,369 shares (13.95%) and Zheng Gang with 7,850,000 shares (4.79%) as of the end of the reporting period [155]. - The company’s core employees, Zheng Genlu and Yang Juhua, have left the company, impacting the shareholding structure [153]. - The company has established a compensation plan for 2024, which was approved by the shareholders' meeting [184]. - The company has not implemented any stock incentive plans for the reporting period [186]. Internal Control and Risk Management - The company is implementing stringent internal controls related to revenue recognition to mitigate risks associated with management's potential manipulation of financial results [104]. - The company emphasizes the importance of internal control management to enhance risk prevention capabilities [116]. - The company has established a comprehensive technical management system and a stable R&D team, accumulating core technologies and products with independent intellectual property rights [120].

证券代码：830974 证券简称：凯大催化 公告编号：2025-013 杭州凯大催化金属材料股份有限公司 董事会审计委员会 2024 年度履职情况报告 | | | | | | | 监督职责情况报告的议案 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | 案 | 关于会计师事务所履职情况评估报告的议 | 审议通过 | | | | | | | | 关于公司 2023 年审计报告的议案 | 审议通过 | | | | | | | 2024 | 年第一季度报告 | 审议通过 | | | | | | | | 关于聘请公司 2024 年度审计机构的议案 | 审议通过 | | 第四届董事会审计 | | | | | 关于 | 2024 年半年度报告及摘要的议案 | 审议通过 | | 委员会第二次会议 | 2024 | 年 8 | 月 | 26 | 日 议案 | 关于前期会计差错更正及定期报告更正的 | 审议通过 | | 第四届董事会审计 委员会第三次会议 | 2024 | 年 | 月 10 | 22 | 日 关于 | 年第三季度报告的议案 202 ...

杭州凯大催化金属材料股份有限公司 关于 2025 年度公司董事、监事及高级管理人员薪酬方案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 杭州凯大催化金属材料股份有限公司（以下简称"公司"）根据《中华人民共 和国公司法》《公司章程》及相关法律、法规和规范性文件的规定，结合经营发展 等实际情况，参考行业、地区薪酬水平，制定了 2025 年度董事、监事及高级管理人 员薪酬方案，现将具体情况公告如下： 一、2025 年度董事、监事及高级管理人员薪酬方案 （一）适用对象 证券代码：830974 证券简称：凯大催化 公告编号：2025-020 （1）公司非独立董事在公司担任管理职务者或参与公司管理的，根据其在公司 所担任的管理职务或岗位领取薪酬；未在公司担任管理职务的非独立董事，不在公 司领取薪酬或津贴； （2）公司独立董事职务津贴为 6 万元/年（税后）。 2、公司监事薪酬方案 公司监事在公司担任管理职务者或参与公司管理的，按照所担任的管理职务领 取薪酬，不领取监事津贴。未担任管理职务或参与公司管理的监 ...

证券代码：830974 证券简称：凯大催化 公告编号：2025-017 一、募集资金基本情况 2023 年 1 月 5 日，经中国证券监督管理委员会作出《关于同意杭州凯大催 化金属材料股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监 许可〔2023〕34 号），同意杭州凯大催化金属材料股份有限公司（以下简称"公 司"）向不特定合格投资者公开发行股票的注册。 杭州凯大催化金属材料股份有限公司 公司本次发行采用战略投资者定向配售和网上向开通北交所交易权限的合 格投资者定价发行相结合的方式进行。公司本次初始发行价格为 6.26 元/股。本 次公开发行股份数量为 1,000.00 万股，行使超额配售选择权发行 150.00 万股， 合计发行 1,150.00 万股。根据中汇会计师事务所（特殊普通合伙）出具的中汇会 验[2023]0524 号《验资报告》，确认截至 2023 年 2 月 28 日止，公司募集资金总 额人民币 6,260.00 万元（行使超额配售选择权前），扣除券商承销费用和保荐费 用合计人民币 543.36 万元（不含增值税，其中保荐费用 141.51 万元（已于发行 前支付），实际募集到账 ...

证券代码：830974 证券简称：凯大催化 公告编号：2025-027 杭州凯大催化金属材料股份有限公司 董事会关于 2024 年度非标准审计意见涉及事项的专项说明 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 中汇会计师事务所(特殊普通合伙)（以下简称"中汇"）对杭州凯大催化金属材料 股份有限公司（以下简称"公司"或"凯大催化公司"）2024 年度财务报告出具了带 有强调事项段的无保留意见的审计报告（审计报告编号：中汇会审[2025]5058 号）， 根据《公开发行证券的公司信息披露编报规则第 14 号——非标准审计意见及其涉及 事项的处理》《北京证券交易所股票上市规则》等相关规定，公司董事会就上述意 见涉及事项说明如下： 一、中汇出具带有强调事项段的无保留意见的情况 我们提醒财务报表使用者关注，如财务报表附注十四、其他重要事项所述，凯 大催化公司于 2025 年 3 月 21 日收到中国证券监督管理委员会(以下简称"中国证监 会")下发的《立案告知书》(编号:证监立案字 01120250008 号 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 根据《上市公司独立董事管理办法》《北京证券交易所股票上市规则》《北京 证券交易所上市公司持续监管指引第 1 号——独立董事》等相关要求，杭州凯大催 化金属材料股份有限公司(以下简称"公司")董事会，就公司在任独立董事朱建林、史 莉佳、彭兵的独立性情况进行评估并出具了专项意见。 根据独立董事向董事会提供的关于独立性情况的自查报告，结合其他相关资料， 董事会就独立董事的独立性形成如下结论： 证券代码：830974 证券简称：凯大催化 公告编号：2025-012 杭州凯大催化金属材料股份有限公司 董事会关于独立董事独立性自查情况的专项报告 综上，董事会认为公司在任独立董事具备任职条件，不存在影响其独立性的情 形。 杭州凯大催化金属材料股份有限公司 （一）独立董事及其配偶、父母、子女、具有主要社会关系的人员未在公司或 公司附属企业任职； （二）独立董事及其配偶、父母、子女未直接或间接持有公司已发行股份百分 之一以上，不是公司前十名股东中的自然人股东； 1 项目组全 ...

证券代码：830974 证券简称：凯大催化 公告编号：2025-010 杭州凯大催化金属材料股份有限公司 2024 年度独立董事述职报告（史莉佳） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人史莉佳作为杭州凯大催化金属材料股份有限公司（以下简称"公司"）的 独立董事，2024 年度严格按照《公司法》《证券法》《上市公司独立董事管理办法》 《北京证券交易所上市公司持续监管指引第 1 号——独立董事》等法律、法规和规 范性文件以及《公司章程》《独立董事工作制度》等相关规定和要求，忠实地履行 独立董事的职责，谨慎、认真、勤勉地行使所赋予的权利，积极出席公司相关会议， 认真审议董事会各项议案，参与公司经营发展的讨论，对公司相关事项发表了公正、 客观的独立意见，充分发挥了独立董事的作用，切实维护了公司和股东尤其是中小 股东的合法权益。现将 2024 年度本人履行独立董事职责的工作情况汇报如下： 一、会议出席情况 1 均认真审议相关议案、发表意见，具体情况如下： （一）出席董事会和股东会情况 2024 年度 ...